Clinical trial
Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer
NCT04021069
Study timeline
Study start (actual)2018-08-30Date precision: day
Registry last updated2019-07-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Invasive Ductal Breast Carcinomaunresolved
Invasive Lobular Breast Carcinomaunresolved
Interventions
Radiomic, pathomic, and clinical markersDIAGNOSTIC_TEST
Sponsors & collaborators
Sunnybrook Health Sciences Centrelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04021069 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.